The latest closing stock price for TransCode Therapeutics as of April 11, 2025 is 0.40.
An investor who bought $1,000 worth of TransCode Therapeutics stock at the IPO in 2021 would have $-1,000 today, roughly -1 times their original investment - a -95.88% compound annual growth rate over 4 years.
The all-time high TransCode Therapeutics stock closing price was 170280.00 on July 12, 2021.
The TransCode Therapeutics 52-week high stock price is 66.34, which is 16485% above the current share price.
The TransCode Therapeutics 52-week low stock price is 0.34, which is 15% below the current share price.
The average TransCode Therapeutics stock price for the last 52 weeks is 15.34.
An investor who bought $1,000 worth of TransCode Therapeutics stock at the IPO in 2021 would have $-1,000 today, roughly -1 times their original investment - a -95.88% compound annual growth rate over 4 years.
The all-time high TransCode Therapeutics stock closing price was 170280.00 on July 12, 2021.
The TransCode Therapeutics 52-week high stock price is 66.34, which is 16485% above the current share price.
The TransCode Therapeutics 52-week low stock price is 0.34, which is 15% below the current share price.
The average TransCode Therapeutics stock price for the last 52 weeks is 15.34.